TLR7: A Key Prognostic Biomarker and Immunotherapeutic Target in Lung Adenocarcinoma.
Hu F, Hu C, He Y, Sun Y, Han C, Zhang X, Yu L, Shi D, Sun Y, Zhang J, Jiang D, Yang S, Yang K.
Hu F, et al.
Biomedicines. 2025 Jan 9;13(1):151. doi: 10.3390/biomedicines13010151.
Biomedicines. 2025.
PMID: 39857735
Free PMC article.